查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1371943

2030 年生物可吸收植入物市場預測：按產品類型、材料類型、用途、最終用戶和地區進行的全球分析

Bioresorbable Implants Market Forecasts to 2030 - Global Analysis By Product Type, Material Type, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球生物可吸收植入物市場規模為 1,113 億美元，預計到 2030 年將達到 2,060.8 億美元，預測期內年複合成長率為 9.2%。

可生物吸收植入物是由最終分解並被人體吸收的材料製成的醫療設備。植入物的生物可吸收成分逐漸擴散到體內，無需進行修復手術即可去除人造材料。生物可吸收植入物有人造材料和天然材料。生物可吸收植入物減少了金屬植入物所需的翻修手術的需要。生物可吸收植入物以支架的形式用於心血管應用，以螺絲和銷釘的形式用於治療骨折和腳踝手術，以網的形式用於治療疝氣和骨盆器官脫垂。

根據世界衛生組織 (WHO) 2017 年 5 月的情況說明書，2016 年約有 1,790 萬人死於心血管疾病，佔全球死亡人數的 31%。

對生物可吸收骨支架的需求不斷成長

骨骼損傷可以使用生物可吸收骨支架進行修復。生物可吸收骨支架逐漸被人體吸收，使新的骨組織發育。由骨折、腫瘤或感染疾病引起的骨缺損可用生物可吸收骨支架取代。此外，支架可作為新骨組織發育的支撐結構，並最終被吸收到體內。骨移植是從身體的一個部位移植到另一個部位的骨碎片，可以使用生物可吸收骨支架來穩定。此支架有助於保持骨移植物的位置，直到它融入周圍的骨頭。可以使用生物可吸收骨支架來治療缺失的骨骼，以刺激骨骼生長。因此，市場成長的需求不斷增加。

材料限制和成本

與不可吸收植入物相比，生物可吸收植入物的材料選擇目前受到限制。儘管經常使用聚合物和陶瓷，但它們的機械性能、分解率和加工方法可能不適合所有用途。此外，由於材料成本、製造程序和法規限制的增加，生物可吸收植入物可能比不可吸收植入物更昂貴。醫療保健專業人士、付款人和患者都在權衡生物可吸收植入物的成本效益，以及它們的使用方式會產生影響。因此，這些都是市場拓展的主要障礙。

加大研發投入

生物可吸收植入物是廣泛研究和開發的主題。可生物吸收的植入物可以減少發炎和感染等問題的機會。這是因為它是使用對人類安全的材料建造的。此外，透過減少翻修手術的需要，生物可吸收植入物可以改善患者的治療效果。這是因為隨著生物吸收的進行，新的組織會在這個位置形成。隨著時間的推移，生物可吸收植入物可能會變得比傳統植入物更便宜。增加的研發資金正在創造新的、更好的生物可吸收植入物。這些要素正在促進市場成長。

缺乏意識和教育

外科醫生、其他專家和全科醫生可能不熟悉或不了解生物可吸收植入物。缺乏知識可能會導致不願意或有限地採用這種新興技術。缺乏知識可能會導致人們在使用生物可吸收植入物之前猶豫不決或不願意改變公認的規範。然而，與不可吸收植入物相比，可能存在強度、壽命和長期功能的擔憂。如果沒有必要的培訓和資訊，醫療保健提供者可能不願意提案或使用生物可吸收植入物，這阻礙了市場的成長。

COVID-19 的影響

COVID-19 大流行對全球生物可吸收植入物市場產生了重大影響。由於疫情爆發導致醫院推遲了整形外科手術等選擇性手術，對生物可吸收植入物的需求受到限制。 COVID-19 透過限制化學和材料行業的運作方式襲擊了全球市場。此外，供應鏈中斷和原料採購挑戰嚴重限制了生物可吸收植入物市場。儘管存在這些短期挑戰，生物可吸收植入物市場預計在未來年度將大幅擴張。

陶瓷領域預計將在預測期內成為最大的產業

預計陶瓷領域將佔據最大佔有率。陶瓷是一種無機非金屬材料，具有特殊性能，非常適合生物可吸收植入物的特定用途。陶瓷因其優異的機械強度、生物相容性和骨傳導性而廣泛應用於生物可吸收植入物中。陶瓷材料可作為骨骼再生的支架，幫助植入物融入周圍組織。陶瓷生物可吸收植入物經常用於需要強大機械性能和結構支撐的情況。

生物網格領域預計在預測期內年複合成長率最高。

預計生物網格領域將在預測期內出現良好的成長。這種可植入材料被稱為“生物網”，是利用人類屍體捐贈者或動物組織等生物資源製成的。在這些網格的製造和加工過程中，支持結構完整性並幫助組織整合的細胞外基質（ECM）被保留，同時細胞成分被移除。由於生物網是由天然材料製成的，因此人體通常能夠很好地耐受它們。與合成材料相比，它不太可能引起免疫反應或排斥反應。身體有能力重建並最終重新吸收生物網。網片逐漸劣化並被新鮮組織取代，從而形成自然修復過程。

比最大的地區

由於心血管疾病高患病和老年人口不斷成長要素，北美在預測期內佔據了最大的市場佔有率，預計這將增加骨質疏鬆症和骨關節炎病例的數量。此外，對整形外科植入物的需求不斷增加，以及不斷開拓先進技術來提高現代治療方法和設備的臨床表現，預計將在預測期內推動北美市場的成長。

複合年複合成長率最高的地區：

由於對生物可吸收植入物的高度認知，預計亞太地區在預測期內將實現盈利成長。亞太地區高齡化率高，人口不斷增加。結果，患有骨質疏鬆症和骨關節炎等慢性疾病的人數不斷增加。生物可吸收植入物可用於治療這些疾病並改善患者的生活品質。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 利害關係人
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球生物可吸收植入物市場：依產品類型

  • 支架
    • 週邊動脈支架
    • 冠狀動脈支架
    • 非血管支架
      • 膽管支架
      • 食道支架
  • 生物網
  • 固定裝置
  • 吸水網
  • 吸收帶
  • 可吸收支架
  • 吸收繫繩

第6章 全球生物可吸收植入物市場：依材料類型

  • 陶瓷
  • 金屬的
  • 聚合物
    • PGA（聚乙交酯）
    • 共聚物
    • PLA（聚乳酸）
  • 其他材質類型

第7章 全球生物可吸收植入物市場：依用途

  • 整形外科
  • 心血管
  • 一般外科
  • 整容手術
  • 顱骨
  • 牙科手術
  • 血管外科

第8章 全球生物可吸收植入物市場：依最終用戶分類

  • 專科診所
  • 醫院
  • 門診手術中心
  • 其他最終用戶

第9章 全球生物可吸收植入物市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第10章 進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章公司簡介

  • Medtronic Plc
  • Dentsply Shiroma.
  • Boston Scientific Corporation
  • Meryl Life Sciences Pvt. Ltd.
  • Stryker Corporation
  • Smith & Nephew Plc
  • KLS Martin
  • Wright Medical Group
  • Biotronik Ltd
  • Syntellix AG
  • JW Medical Systems LTD
  • Q3 Medical Devices Limited.
  • Orbusneich Medical.
  • Depuy Synthes
  • Bioretec Ltd
  • Conmed Corporation
  • Zimmer Biomet Holdings, Inc.
Product Code: SMRC24000

According to Stratistics MRC, the Global Bioresorbable Implants Market is accounted for $111.3 billion in 2023 and is expected to reach $206.08 billion by 2030 growing at a CAGR of 9.2% during the forecast period. Bioresorbable implants are medical devices that are made from materials that are eventually broken down and absorbed by the body. The implants' bioresorbable components gradually diffuse in the body, negating the need for a second operation to remove the artificial material. The bioabsorbable implants can be made of both artificial and natural materials. The bioabsorbable implants will reduce the need of second surgery which is required in the case of metallic implants. The bioabsorbable implants are used in many applications such as cardiovascular in the form of stents, screws and pins are used in orthopedics for the treatment of fractures and ankle surgeries, also the implants are used in the form of mesh for the treatment of hernia and Pelvic organ prolapsed.

According to the World Health Organization (WHO) May 2017, factsheet around 17.9 million people died due to cardiovascular disease in 2016, accounting for 31% of all worldwide deaths.

Market Dynamics:

Driver:

Rising demand for bioresorbable bone scaffolds

Bone injuries can be repaired using bioresorbable bone scaffolds. They are progressively absorbed by the body, allowing for the development of new bone tissue. Bone deficiencies brought on by fractures, tumours, or infections can be filled with bioresorbable bone scaffolds. Additionally, the scaffold acts as a support structure for the development of new bone tissue, and it is eventually absorbed by the body. Bone grafts, or fragments of bone that are transplanted from one area of the body to another, can be stabilised using bioresorbable bone scaffolds. The scaffold aids in maintaining the position of the bone graft until it is assimilated into the surrounding bone. Insufficient bone can be treated with bioresorbable bone scaffolds to encourage bone development. Thus, there is an increasing demand for market growth.

Restraint:

Material limitations & cost considerations

In contrast to non-resorbable implants, the selection of materials for bioresorbable implants is currently constrained. Although polymers and ceramics are frequently used, not all applications may be suited to their mechanical characteristics, rates of degradation, or processing methods. Additionally, due to the increased cost of materials, manufacturing procedures, and regulatory restrictions, bioresorbable implants may be more expensive than non-resorbable implants. Healthcare professionals, insurers, and patients all heavily weigh the cost-effectiveness of bioresorbable implants, which can have an impact depending on how they are used. Therefore, these are significant barriers to the market expansion.

Opportunity:

Rising investment in research and development

Bioresorbable implants are the subject of extensive research and development. They can lower the possibility of problems like inflammation and infection. This is due to the fact that they are constructed using substances that are safe for the human body. Additionally, by lowering the need for revision surgery, bioresorbable implants can enhance patient outcomes. This occurs as a result of their progressive body absorption, which enables new tissue to develop in their place. Over time, bioresorbable implants may cost less than conventional implants. New and better bioresorbable implants are being created due to increased funding for research and development. These factors expand the market growth.

Threat:

Lack of awareness and education

Surgeons and other medical specialists, as well as physicians generally, might not be very familiar with or knowledgeable about bioresorbable implants. Lack of knowledge may cause reluctance or limited adoption of this more recent technology. Lack of knowledge may cause people to hesitate before using bioresorbable implants or to be reluctant to change accepted norms. However, in comparison to non-resorbable implants, they can be concerned about the strength, longevity, or long-term functioning of these implants. Healthcare providers may be reluctant to suggest or utilise bioresorbable implants without the necessary training and information, which hinders market growth.

COVID-19 Impact

The COVID-19 pandemic had a profound effect on the world market for bioabsorbable implants. The demand for bioresorbable implants was limited as a result of hospitals deferring elective treatments like orthopaedic surgery because of the epidemic. The COVID-19's limitations on how the chemicals and materials industry operates have hurt the worldwide market. Additionally, due to supply chain disruptions and challenges sourcing raw materials, the market for bioresorbable implants has been severely restricted. The market for bioabsorbable implants is anticipated to expand dramatically over the coming years, despite these short-term challenges.

The ceramics segment is expected to be the largest during the forecast period

The ceramics segment is estimated to hold the largest share. Ceramics are inorganic, non-metallic materials with special qualities that make them ideal for certain uses in bioresorbable implants. Ceramics are widely employed in bioresorbable implants because to their superior mechanical strength, biocompatibility, and osteoconductive qualities. Ceramic materials can act as a scaffold for bone re growth and make it easier for the implant to blend in with the surrounding tissue. Bioresorbable implants made of ceramic are frequently utilised in situations where strong mechanical performance and structural support are necessary.

The biological meshes segment is expected to have the highest CAGR during the forecast period

The biological meshes segment is anticipated to have lucrative growth during the forecast period. Implantable materials called "biological meshes" are created using biological resources like human cadaver donors or animal tissues. Extracellular matrix (ECM), which supports structural integrity and aids in tissue integration, is preserved in these meshes' processing and treatment while cellular components are eliminated. The body usually tolerates biological meshes well because they are made of natural materials. Compared to synthetic materials, they are less susceptible to immunological reactions or rejection. The body has the capacity to restructure and eventually resorb biological meshes. A natural mending process is brought about by the mesh gradually deteriorating and being replaced by fresh tissue.

Region with largest share:

North America commanded the largest market share during the extrapolated period owing to factors such as a high prevalence of cardiovascular disease and an increase in the geriatric population, which is expected to increase the number of cases of osteoporosis and osteoarthritis. Moreover, rise in demand for orthopedic implants and continuous development of advanced technologies to improve the clinical performance of contemporary treatment modalities and devices are projected to fuel the growth of the market in North America during the forecast period.

Region with highest CAGR:

Asia-Pacific is expected to witness profitable growth over the projection period due to extensive awareness about the bioresorbable implants; these areas are most likely to be potential markets for bioresorbable implant in the region. The Asia-Pacific region has a large and growing aging population. This is leading to an increase in the number of people with chronic diseases, such as osteoporosis and osteoarthritis. Bioresorbable implants can be used to treat these diseases and improve the quality of life of patients.

Key players in the market:

Some of the key players in the Bioresorbable Implants Market include: Medtronic Plc, Dentsply Shiroma., Boston Scientific Corporation, Meryl Life Sciences Pvt. Ltd., Stryker Corporation, Smith & Nephew Plc, KLS Martin, Wright Medical Group, Biotronik Ltd, Syntellix AG, JW Medical Systems LTD, Q3 Medical Devices Limited., Orbusneich Medical., Depuy Synthes, Bioretec Ltd, Conmed Corporation and Zimmer Biomet Holdings, Inc.

Key Developments:

In September 2022, Biotronik Ltd Announces Collaboration with AliveCor As First In A Series of Strategic Partnerships to Disrupt Cardiac Digital Health With AI-Enabled Solutions. This partnership aims to enable faster diagnosis, more informed clinical decision-making and effective treatment by bringing complete information to every step in the diagnosis, device implant, and management process.

In February 2021, Stryker Corporation and Brainomix announced a new partnership that will represent a transformative solution for stroke networks across EMEA, enabling broader utilization of stroke imaging AI tools to help more patients gain access to life-saving treatments.

Product Types Covered:

  • Stents
  • Biological Meshes
  • Fixation Devices
  • Resorbable Mesh
  • Resorbable Band
  • Resorbable Scaffolds
  • Resorbable Tethers

Material Types Covered:

  • Ceramics
  • Metallic
  • Polymers
  • Other Material Types

Applications Covered:

  • Orthopedics
  • Cardiovascular
  • General Surgery
  • Cosmetic Surgery
  • Cranial
  • Dental Surgery
  • Vascular Surgery

End Users Covered:

  • Specialty Clinics
  • Hospitals
  • Ambulatory Surgical Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Bioresorbable Implants Market, By Product Type

  • 5.1 Introduction
  • 5.2 Stents
    • 5.2.1 Peripheral Artery Stents
    • 5.2.2 Coronary Artery Stents
    • 5.2.3 Non vascular Stents
      • 5.2.3.1 Biliary Stents
      • 5.2.3.2 Esophageal Stents
  • 5.3 Biological Meshes
  • 5.4 Fixation Devices
  • 5.5 Resorbable Mesh
  • 5.6 Resorbable Band
  • 5.7 Resorbable Scaffolds
  • 5.8 Resorbable Tethers

6 Global Bioresorbable Implants Market, By Material Type

  • 6.1 Introduction
  • 6.2 Ceramics
  • 6.3 Metallic
  • 6.4 Polymers
    • 6.4.1 PGA (Polyglycolide)
    • 6.4.2 Co-Polymers
    • 6.4.3 PLA (Polylactide)
  • 6.5 Other Material Types

7 Global Bioresorbable Implants Market, By Application

  • 7.1 Introduction
  • 7.2 Orthopedics
  • 7.3 Cardiovascular
  • 7.4 General Surgery
  • 7.5 Cosmetic Surgery
  • 7.6 Cranial
  • 7.7 Dental Surgery
  • 7.8 Vascular Surgery

8 Global Bioresorbable Implants Market, By End User

  • 8.1 Introduction
  • 8.2 Specialty Clinics
  • 8.3 Hospitals
  • 8.4 Ambulatory Surgical Centers
  • 8.5 Other End Users

9 Global Bioresorbable Implants Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Medtronic Plc
  • 11.2 Dentsply Shiroma.
  • 11.3 Boston Scientific Corporation
  • 11.4 Meryl Life Sciences Pvt. Ltd.
  • 11.5 Stryker Corporation
  • 11.6 Smith & Nephew Plc
  • 11.7 KLS Martin
  • 11.8 Wright Medical Group
  • 11.9 Biotronik Ltd
  • 11.10 Syntellix AG
  • 11.11 JW Medical Systems LTD
  • 11.12 Q3 Medical Devices Limited.
  • 11.13 Orbusneich Medical.
  • 11.14 Depuy Synthes
  • 11.15 Bioretec Ltd
  • 11.16 Conmed Corporation
  • 11.17 Zimmer Biomet Holdings, Inc.

List of Tables

  • Table 1 Global Bioresorbable Implants Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Bioresorbable Implants Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Bioresorbable Implants Market Outlook, By Stents (2021-2030) ($MN)
  • Table 4 Global Bioresorbable Implants Market Outlook, By Peripheral Artery Stents (2021-2030) ($MN)
  • Table 5 Global Bioresorbable Implants Market Outlook, By Coronary Artery Stents (2021-2030) ($MN)
  • Table 6 Global Bioresorbable Implants Market Outlook, By Non vascular Stents (2021-2030) ($MN)
  • Table 7 Global Bioresorbable Implants Market Outlook, By Biological Meshes (2021-2030) ($MN)
  • Table 8 Global Bioresorbable Implants Market Outlook, By Fixation Devices (2021-2030) ($MN)
  • Table 9 Global Bioresorbable Implants Market Outlook, By Resorbable Mesh (2021-2030) ($MN)
  • Table 10 Global Bioresorbable Implants Market Outlook, By Resorbable Band (2021-2030) ($MN)
  • Table 11 Global Bioresorbable Implants Market Outlook, By Resorbable Scaffolds (2021-2030) ($MN)
  • Table 12 Global Bioresorbable Implants Market Outlook, By Resorbable Tethers (2021-2030) ($MN)
  • Table 13 Global Bioresorbable Implants Market Outlook, By Material Type (2021-2030) ($MN)
  • Table 14 Global Bioresorbable Implants Market Outlook, By Ceramics (2021-2030) ($MN)
  • Table 15 Global Bioresorbable Implants Market Outlook, By Metallic (2021-2030) ($MN)
  • Table 16 Global Bioresorbable Implants Market Outlook, By Polymers (2021-2030) ($MN)
  • Table 17 Global Bioresorbable Implants Market Outlook, By PGA (Polyglycolide) (2021-2030) ($MN)
  • Table 18 Global Bioresorbable Implants Market Outlook, By Co-Polymers (2021-2030) ($MN)
  • Table 19 Global Bioresorbable Implants Market Outlook, By PLA (Polylactide) (2021-2030) ($MN)
  • Table 20 Global Bioresorbable Implants Market Outlook, By Other Material Types (2021-2030) ($MN)
  • Table 21 Global Bioresorbable Implants Market Outlook, By Application (2021-2030) ($MN)
  • Table 22 Global Bioresorbable Implants Market Outlook, By Orthopedics (2021-2030) ($MN)
  • Table 23 Global Bioresorbable Implants Market Outlook, By Cardiovascular (2021-2030) ($MN)
  • Table 24 Global Bioresorbable Implants Market Outlook, By General Surgery (2021-2030) ($MN)
  • Table 25 Global Bioresorbable Implants Market Outlook, By Cosmetic Surgery (2021-2030) ($MN)
  • Table 26 Global Bioresorbable Implants Market Outlook, By Cranial (2021-2030) ($MN)
  • Table 27 Global Bioresorbable Implants Market Outlook, By Dental Surgery (2021-2030) ($MN)
  • Table 28 Global Bioresorbable Implants Market Outlook, By Vascular Surgery (2021-2030) ($MN)
  • Table 29 Global Bioresorbable Implants Market Outlook, By End User (2021-2030) ($MN)
  • Table 30 Global Bioresorbable Implants Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 31 Global Bioresorbable Implants Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 32 Global Bioresorbable Implants Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 33 Global Bioresorbable Implants Market Outlook, By Other End Users (2021-2030) ($MN

)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.